Literature DB >> 20647251

Thrombotic microangiopathy and the antiphospholipid syndrome.

S J A Johnsen1, T Valborgland, E Gudlaugsson, L Bostad, R Omdal.   

Abstract

The antiphospholipid syndrome (APS) comprises the association between vascular thrombosis, including microthrombosis, pregnancy morbidity and the coexistence of anti-phospholipid antibodies. Thrombotic microangiopathy (TMA) can be one of the manifestations of the APS and may involve any organ. This feature of the APS is probably less recognized by clinical doctors than venous thrombosis and recurrent abortions. This case report presents a patient who developed a widespread TMA with renal failure, gastric mucosa ulceration, urinary bladder ulcerations and a finger necrosis as part of the APS.

Entities:  

Mesh:

Year:  2010        PMID: 20647251     DOI: 10.1177/0961203310375262

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  5 in total

Review 1.  Thrombocytopenia in pregnancy.

Authors:  Douglas B Cines; Lisa D Levine
Journal:  Blood       Date:  2017-06-21       Impact factor: 22.113

Review 2.  Thrombocytopenia in pregnancy.

Authors:  Douglas B Cines; Lisa D Levine
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

3.  Liver transplantation in a patient with primary antiphospholipid syndrome and Budd-Chiari syndrome.

Authors:  Tatiana M Reshetnyak; Natalia V Seredavkina; Maria A Satybaldyeva; Evgeniy L Nasonov; Vasiliy I Reshetnyak
Journal:  World J Hepatol       Date:  2015-09-08

4.  A Very Rare Case of Mass-Like Mesenteric Fat Necrosis in a Patient with Antiphospholipid Syndrome.

Authors:  Ana Luísa Lourenço; João Lopes Dias; Joana Marques; Vera Bernardino
Journal:  GE Port J Gastroenterol       Date:  2020-06-11

Review 5.  TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities.

Authors:  Kun-Hua Tu; Pei-Yi Fan; Tai-Di Chen; Wen-Yu Chuang; Chao-Yi Wu; Cheng-Lung Ku; Ya-Chung Tian; Chih-Wei Yang; Ji-Tseng Fang; Huang-Yu Yang
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.